FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB2 days ago · The FTC’s Bureau of Competition makes clear in a statement issued today that the PBMs are not the only potentially culpable actors – the Bureau also remains deeply troubled by the role drug manufacturers like Eli Lilly, Novo Nordisk, and Sanofi play in driving up list prices of life-saving medications like insulin. Indeed, all drug ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · PBMs, which serve as middlemen in the drug supply chain by negotiating rebates with drug manufacturers on behalf of insurers, large employers and others, could be steering patients to their own...
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
FTC sues the three largest PBMs for allegedly inflating the cost of ...
WEB2 days ago · September 20, 2024 at 2:20 p.m. EDT. The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their ...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB2 days ago · September 20, 2024 / 3:09 PM EDT / CBS News. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while ...
FTC sues insulin middlemen, saying they pocket billions while …
WEB1 day ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly ...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
How FTC's Battle With PBMs Could Reshape The Pharmaceutical ... - Forbes
WEBJul 20, 2024 · Now, PBMs are center stage for the FTC. The Federal Trade Commission has turned its attention to these powerful intermediaries and is, according to the Wall Street Journal, considering a lawsuit...
FTC to sue PBMs over drug prices including insulin, source says
WEBJul 10, 2024 · The FTC has been investigating PBMs since 2022. The investigation into insulin prices also examines drugmakers, but it is unclear whether they will be named in the upcoming lawsuits, Politico...
Skip to content